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Abstract 
How important is resource depletion (e.g. depletion of target cells) in controlling infection 
within a host? And how can we distinguish between resource depletion and other 
mechanisms that may contribute to decline of pathogen load or lead to pathogen clearance? 
In this paper we examine data from a previously published experiment. In this experiment, 
mice were infected with influenza virus carrying a green fluorescent protein reporter gene, 
and the proportion of lung epithelial cells that were influenza infected was measured as a 
function of time. Three inoculum dose groups - 104 PFU, 106 PFU and 107 PFU - were used. 
The proportion of cells infected was estimated to be about 21 (95% confidence interval: 
14-32) fold higher in the highest dose group than in the lowest dose group with the middle 
dose group in between. We show that this pattern is highly inconsistent with a model 
where target cell depletion is the principal means of controlling infection, and we argue 
that such a pattern constitutes a reasonable criterion for rejecting many resource depletion 
models. A model with an innate interferon response that renders susceptible cells resistant 
fits the data reasonably well. This model suggests that target cell depletion is only a minor 
factor in controlling natural influenza infection. 
Introduction 
It is well known that adaptive immunity (antibodies and T cells) can control influenza and 
other infections within host [1]. Yet experimental data, such as the data analyzed in this 
paper [2] as well as other data [3] [4], shows that primary infection often peaks very early - 
within a few days of infection - even in naive hosts. In these instances the infection begins 
to decline substantially earlier than what might be expected if adaptive immunity were the 
main factor in controlling infection [5] [6]. This suggests that innate immunity may be 
responsible for controlling infection with adaptive immunity becoming important some 
days later and helping to clear the infection. An alternative explanation is resource 
depletion. In this framework the infection uses up some resource - for example target cells 
in the case of viral infection - and depletion of this resource is what controls infection. 
In fact target cell depletion has been proposed as a mechanism for controlling influenza 
infection [7]. The model has been shown to fit influenza virus load dynamics well [7]. And 
mathematical modeling studies previously showed that the viral load kinetics can in 
general be well described by the target cell depletion mechanism (reviewed in e.g. [8] [9]). 
But the model may seem scientifically unsatisfying in that it suggests that the adaptive and 
innate immune responses have a very limited role in controlling infection. Either the 
infection does not take off (R0 less than 1) or a majority of susceptible cells are killed (R0 
substantially greater than 1) - only for a narrow range of R0 is other behavior observed; 
here R0 is the basic reproduction number for cell to cell transmission within a host [10]. 
Saenz et al [3] have analyzed data of influenza infection in ponies. They observed cell death 
of only 27% at the end of influenza infection and argue that target cell depletion cannot 
explain this result. But latent heterogeneity in which only a subset of supposedly 
susceptible cells are actually susceptible to infection [11] could easily explain this result. In 
fact the data from Saenz et al can be fit almost perfectly with a target cell depletion model 
under the assumption that only a fraction of lung epithelial cells are actually susceptible 
(see supplement S1). Therefore another means of distinguishing between target cell 
depletion and other models is needed. 
One way of distinguishing between target cell depletion and immunity in controling 
infection is by perturbing (typically depleting) various components of the immune system. 
Comparing different mechanistic models with data from such experiments has provided 
one way of determining the role of different components of immunity in the control of 
influenza virus infection [6]. However, experiments which deplete components of the 
immune system are not ethically feasible in humans. In contrast human infection challenge 
studies that vary the inoculum dose may be more ethically feasible. 
In this paper we build on earlier models that explore the impact of innoculum dose on the 
dynamics of infection [12]. We show that the relationship between inoculum dose and final 
size (the total number of cells infected during infection) can allow rejection of the resource 
depletion model. We then show that based on this criterion data from a mouse influenza 
experiment strongly suggests mechanisms other than resource depletion. Finally we 
describe an interferon model that fits this data well. This interferon model suggests that for 
lower more physiological inoculum doses target cell depletion plays only a miniscule role 
in limiting influenza infection. 
Results and discussion 
Criterion for distinguishing between resource depletion and other models 
One of the simplest resource depletion models is the classical susceptible infected removed 
(SIR) model developed by Kermack and McKendrick [13]. This model was originally 
proposed to model between host spread of an infection within a community. A 
mathematically equivalent and conceptually analogous model can be used to model 
between cell spread of infection within a host. 
             
                
          
Here S is the number of susceptible cells. I is the number of infected cells, and R is the 
number of removed (i.e. dead or otherwise unavailable) cells. (For between host models R 
some times stands for recovered.) Since R=N-S-I it is not necessary to explicitly model all 
three compartments; here N is the number of susceptible plus infected cells at time zero i.e. 
at the beginning of the infection. (This model does not include an explicit equation for the 
parasite; infected cells produce new infected cells via the unmodeled production of 
parasites.) 
The final size (F) is the total number of cells infected during the infection. For the Kermack 
Mckendrick model the final size is given by 
                         
         
where W is the upper branch of the Lambert W function and I(0) is the number of infected 
cells at time zero. R0=N*r/b. (See supplement S2 for a derivation of this final size formula.) 
In this model I(0) corresponds to inoculum dose. 
The maximum fold change (M) in final size due to changes in I(0) can be derived from the 
final size formula. 
            
        
   
Inverting this equation gives 
                
. As shown in figure 1 M decreases as R0 increases such that M approaches 1 for higher 
values of R0. 
 
Fig 1. M vs R0 in the Kermack McKendrick model. M, the maximum fold change in final size 
due to changes in inoculum dose, is close to 1 in the Kermack McKendrick model except at 
very low values of R0. Hence M>2 seems a reasonable criterion for rejecting models like the 
Kermack McKendrick model where resource depletion is the only means of control. 
Remarkably the Kermack McKendrick final size formula also gives the final size for more 
complicated resource depletion models; this includes models in which infected cells 
progress through multiple infectious stages and those in which certain cell populations are 
more infectious than others [14] [15]. Moreover explicitly including a parasite 
compartment requires only a small change to the final size formula (to accommodate an 
initial condition than includes parasite count) whereas the formula for M remains 
unchanged (supplement S3). 
Therefore the relationship between inoculum dose, R0 and F is a means of distinguishing 
between target cell depletion and other mechanisms of control. In the variety of models 
mentioned in the previous paragraph M>2 requires R0<1.39. Such low values of R0 are 
unlikely for several reasons. 1) These values overlap only a small portion of the viable 
range of R0;      being inviable. 2) Such low R0 suggests lack of robustness; conditions 
that are even slightly unfavorable to the parasite could cause R0 to drop to 1 or below. 3) 
Low R0 corresponds to high risk of early stochastic extinction (i.e. stochastic extinction 
when only a small number of cells have been infected); under typical assumptions the 
probability of early stochastic extinction is 1/R0 [16]. Therefore we suggest that greater 
than 2 fold increase in final size from increase in inoculum dose is a reasonable criterion to 
suggest that mechanisms other than resource depletion play an important role. 
Target cell depletion cannot explain Manicassamy data 
Here we examine data from Manicassamy et al [2] augmented with previously unpublished 
data from the same experiment. In this experiment, naive mice were infected with 
influenza virus carrying a green fluorescent protein gene, and the proportion of lung 
epithelial cells that were influenza infected was measured. Three inoculum dose groups - 
104 PFU, 106 PFU and 107 PFU - were used. As expected from the study design I(0) seems to 
increase with dose (figure 2). 
 
Fig 2. Infected cells by day and inoculum dose. This figure shows the proportion of lung 
epithelial cells that are influenza infected according to green fluorescent protein expression. 
Proportions were adjusted for background fluorescence by subtracting the mean of the 
control group. Infected proportions appear to increase with dose. 
The final size is proportional to the integral or area under the curve (AUC) of infected cells 
over time. Because the infection seems to be clearing by day 4 and because for the 104 PFU 
and 107 PFU groups we only have data until day 4, we use the AUC over the first 4.5 days to 
approximate the final size. 
The AUC is much higher in the 107 PFU group as compared to the 104 PFU group (~21 fold 
difference, 95% confidence interval: 14-32). The AUC in the 106 PFU group is also much 
higher than in the 104 PFU group (~9.1 fold difference, 95% confidence interval: 6.1-14). 
The difference in AUC between the two higher dose groups is also statistically significant 
(~2.3 fold difference, 95% confidence interval: 1.7-3.2). Figure 3 shows the AUCs by dose 
group. 
 
Fig 3. Mean AUC by dose with 95% confidence interval. AUC (infected cells over time) is 
much higher in the high and middle dose groups compared to the low dose group. The 
difference between the two higher dose groups is also statistically significant (p<0.05). This 
pattern, large variation in AUC with inoculum dose, is suggestive of control mechanisms 
other than resource depletion. 
Therefore this data is highly inconsistent with the Kermack McKendrick model unless R0 is 
implausibly small (R0<1.04). In contrast Baccam et al [7] estimate an R0 of 22 for influenza. 
Furthermore since the initial growth rate, dln(I)/dt at time zero, equals ((1-I(0)/N)*R0-
1)*b a very high death rate (b) is needed to fit the early growth rate if R0 is low. 
Model with interferon response can explain data 
Because the infection peaks around or before day 3 in all three inoculum dose groups and 
because this is primary infection data, it seems unlikely that adaptive immunity is a major 
factor in controlling the infection. Because influenza is a viral infection, the role of 
phagocyte activation seems relatively less important. Therefore we propose a model in 
which type I interferon causes susceptible cells to become resistant to infection similar to 
[3]. 
               
                
           
         
Here R1 is dead cells. R2 is cells that have become resistant in response to interferon. X is 
interferon mediated conversion of susceptible cells to resistant. If X=k*S*I then the model 
is mathematically equivalent to a Kermack McKendrick model and therefore suffers from 
the same limitations. Realistically, infected cells produce interferon with some delay 
relative to time of infection, interferon diffuses and after some time, depending on the local 
concentration of interferon, susceptible cells convert to a resistant phenotype. Therefore 
accurately modeling X may involve multiple delays and spatial consideration. However, for 
this data                         fits reasonably well. Here infected cell produce 
interferon with lag l1 and susceptible cells respond to interferon with lag l2. Because of lack 
of identifiability we assume l1=l2 so the model simplifies to                     
where l=l1+l2. 
For fitting the model we used the mean for each group at each time point. As shown in 
figure 4 the model fits the means well; table 1 shows the parameter values used. 
 Fig 4. Interferon model. The interferon model closely matches the means of each group. 
Table 1. Parameter values for interferon model 
Parameter Value Units 
I(0) 0.000016, 0.0016, 0.016* proportion of lung epithelial cells 
N 0.132 proportion of lung epithelial cells 
r 24.1 1/days 
b 0.355 1/days 
k 28500 1/days 
l1+l2 1.47 days 
All values are based on fitting to the data. See methods section for more information. *For 
low, middle and high dose groups respectively; 1:100:1000 ratio was forced. 
Implications of interferon model 
Because all three doses in the Manicassamy experiment were lethal, we use half of the 
lowest inoculum dose for this section (i.e. we use I(0)=0.000008). For consistency with 
earlier sections and because adaptive immunity is likely to clear the infection, we focus on 
the first 4.5 days. We assume that the severity and transmissibility of infection is given by 
AUC over the first 4.5 days. We assume that k and l2 are purely host dependent parameters, 
so we focus on N, r, b and l1 which we consider to be dependent on both virus and host. 
Table 2 shows the impact of these parameters on AUC. 
Table 2. Influence of model parameters 
Parameter dln(AUC)/dln(parameter) 
N 5.42 
r 5.36 
b -0.72 
l1 1.97 
The model suggests that N and r have the greatest impact on transmissibility and severity 
and l1 also has a large impact. These results are consistent with claims that the highly 
pathogenic 1918 H1N1 strain more readily infected cells deep in the lung (higher N), 
replicates to higher titers in vitro (higher N or r) and more effectively blocked interferon 
production (higher l1) [17] [18]. b has a smaller but still substantial impact. This is 
consistent with the cytolytic nature of influenza. Since a large drop in b would be offset by a 
small drop in N, r or l1, evolution would favor a cytolytic strain with slightly higher N, r or l1 
over a noncytolytic strain. 
In this scenario the role of target cell depletion is miniscule; depletion of target cells 
reduces AUC by 5% compared to an otherwise equivalent model in which infection does 
not reduce the number of susceptible cells. In contrast interferon reduces AUC by 92%. 
This suggests that resource depletion plays only a minor role in controlling influenza 
infection. 
Concluding comments 
Mathematical models have proved a useful tool for understanding the dynamics of virus 
infections [19] and have been widely applied to influenza infections [7] [20] [21] [22] [23] 
[24] [25] [26] [27] [28]. 
In this paper we focus on distinguishing between resource depletion and other 
mechanisms of control. We propose a means of rejecting resource depletion models. 
Namely we suggest that a substantial (>2 fold) increase in AUC with increase in I(0) is a 
criterion to reject resource depletion only models. Because of its simplicity and tractability, 
we focus on the Kermack McKendrick model. But we believe that our criterion is valid for 
many well mixed resource depletion models. In contrast a resource depletion model that is 
not well mixed may have different dynamics [29][30]. For example consider a spatial SIR 
model where there are islands of susceptibles and infection rarely jumps between islands. 
If higher I(0) corresponds to a larger number of infected islands at time zero, one might 
find a large increase in AUC with increasing I(0). But, while plausible for certain scenarios, 
we consider this model biologically implausible as a within host model for influenza. 
It is important to note that our criterion for rejecting resource depletion does not work in 
the converse; near constant AUC with changing I(0) is not a strong argument in favor of 
resource depletion even when the resource depletion model fits pathogen load data well. In 
particular when there is no delay (l1+l2=0) our interferon model is mathematically 
equivalent to a target cell depletion model when it comes to fitting the time courses of 
infected and dead cells. But even in this case the interferon model allows interferon to play 
a much larger role than target cell depletion in terms of control of infection, so the models 
are conceptually quite different despite being in a sense mathematically equivalent. In this 
case distinguishing between the models would require additional data, different analyses 
or stronger assumptions. 
Many factors such as resource depletion, innate and adaptive immunity can contribute to 
the control of infections and it is not always simple to determine their contributions. One 
approach to discriminating between models is to determine their ability to recapitulate the 
dynamics of the pathogen following a typical infection initiated by a fixed inoculum. 
However, the basic pattern of acute infections - an exponential growth phase followed by 
control and clearance - can be recapitulated by models with any of the above mechanisms. 
Consequently alternative approaches may be more powerful. One approach is to confront 
models with data showing how the pathogen dynamics change with innoculum dose [12]. 
Here we showed how such an analysis can allow rejection of the resource depletion 
hypothesis for influenza. 
Methods 
Experimental data 
The experimental data comes from a previously published study. See [2] for details. The 
mouse experiments were approved by the Institutional Animal Care and Use Committee of 
Mount Sinai School of Medicine and conducted in accordance with their guidelines. 
Data analysis methods 
To calculate AUCs from the Manicassamy et al data, replicates were averaged then the 
rectangle method was applied. Confidence intervals for the AUCs were calculated via 
bootstrap using 100000 resamples; bootstrap was stratified by dose group and time point. 
The interferon model was fit by minimizing 
                       
                                       
   where 
mAUC is the model AUC, I is the proportion of infected cells averaged across replicates, mI 
is the modeled proportion of infected cells, i represents the dose groups and j represents 
time points with data. This inverse hyperbolic sine transformation is similar to a linear 
transformation for small values of I and mI and similar to natural log transformation for 
values of I and mI that are larger than 0.01. For fitting the lowest dose group I=0 was 
imputed for days 5, 6 and 7. 
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S3. Appendix. Final size of a virus explicit resource depletion model. 
S1. Kermack McKendrick model can fit Saenz data 
Saenz et al [3] analyze primary influenza infection data from ponies. At days 2.5, 4.5 and 5.5 
1.93%, 4.73% and 1.87% of lung epithelial cells were estimated to be infected. Saenz et al 
argue that this data is inconsistent with target cell depletion models because a majority of 
cells appear to have escaped infection. In fact this result can easily be explained by latent 
heterogeneity such that only a subset of cells are susceptible to infection. A Kermack 
McKendrick model with I(0)=5.99*10-7, N=0.195, r=26.6 and b=1 fits the data almost 
perfectly; here the units are proportion of lung epithelial cells for I(0) and N and inverse 
days for r and b. 
 Saenz et al argue this data is inconsistent with target cell depletion being the only means of 
control. But in contradiction to this argument a Kermack McKendrick model fits the data 
almost perfectly. 
S2. Derivation of final size formula for the Kermack McKendrick 
model 
             
                
We can solve explicitly for I as a function of S 
               
                        
Solving for initial condition I(0)=N-S(0), 
                                
At the end of infection I=0 and S=N-F where F is the final size so 
                                    
                            
since R0=N*r/b 
Therefore 
                     
                      
                
       
                                
           
                                  
                                  
where W is the Lambert W function which has the property that W(z*ez)=z. The Lambert 
W function has two branches since z*ez=z has up to two real solutions. The upper branch 
of the Lambert W function gives the correct value for F. 
S3. Final size of a virus explicit resource depletion model 
A virus explicit model is shown below. 
              
             
                
          
Here, V is quantity of virus, S is the number of susceptible cells, I is the number of infected 
cells, and R is the number of dead cells. 
The final size of this model is given by a modified Kermack McKendrick final size formula. 
                        
         
                             
Here, N=S(0)+I(0), W is the upper branch of the Lambert W function, R0=N*p*r/a/b and 
EIZ can be interpreted as the dose of infected cells without virus that is equivalent to a dose 
of V(0) virus and I(0) infected cells. For V(0)=0 the above formula simplifies to the 
standard Kermack McKendrick final size formula. 
The modified final size formula can be derived from a probabilistic argument. Let A be 
infectious contact with virus produced by infected cells, and let B be infectious contact with 
the initial stock of virus. Here infectious contact means contact that would have caused 
infection had the cell been susceptible. 
                     
It can be shown that                and                 . Solving for F gives the 
modified final size formula. Notably this probabilistic argument and this modified final size 
formula apply also to more complicated resource depletion models; this includes models in 
which infected cells progress through multiple infectious stages and those in which certain 
cell populations are more infectious than others [15]. 
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